The estimated Net Worth of Pacific Med Tech (Bvi) Ltd ... is at least 5.26 百万$ dollars as of 23 January 2018. Pacific Ltd owns over 684,288 units of Sorrento Therapeutics Inc stock worth over 86,175$ and over the last 7 years Pacific sold SRNE stock worth over 5,173,217$.
Pacific has made over 1 trades of the Sorrento Therapeutics Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently Pacific sold 684,288 units of SRNE stock worth 5,173,217$ on 23 January 2018.
The largest trade Pacific's ever made was selling 684,288 units of Sorrento Therapeutics Inc stock on 23 January 2018 worth over 5,173,217$. On average, Pacific trades about 684,288 units every 0 days since 2018. As of 23 January 2018 Pacific still owns at least 8,617,513 units of Sorrento Therapeutics Inc stock.
You can see the complete history of Pacific Ltd stock trades at the bottom of the page.
Over the last 15 years, insiders at Sorrento Therapeutics Inc have traded over 17,198,839$ worth of Sorrento Therapeutics Inc stock and bought 10,353,437 units worth 10,703,222$ . The most active insiders traders include Jane Ph D Hsiao、Edgar Lee、Patrick Chan Soon Shiong Fa.... On average, Sorrento Therapeutics Inc executives and independent directors trade stock every 60 days with the average trade being worth of 2,947$. The most recent stock trade was executed by Henry Ji on 7 September 2022, trading 88,888 units of SRNE stock currently worth 179,554$.
sorrento therapeutics is an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases. sorrento's lead products are multiple late-stage biosimilar and biobetter antibodies, as well as clinical car-t therapies targeting solid tumors.
Sorrento Therapeutics Inc executives and other stock owners filed with the SEC include: